20-YEAR FOLLOW-UP OF THE BREAST-CANCERS DIAGNOSED DURING THE BREAST-CANCER DETECTION DEMONSTRATION PROJECT

Citation
Cr. Smart et al., 20-YEAR FOLLOW-UP OF THE BREAST-CANCERS DIAGNOSED DURING THE BREAST-CANCER DETECTION DEMONSTRATION PROJECT, Ca, 47(3), 1997, pp. 134-149
Citations number
21
Categorie Soggetti
Oncology
Journal title
CaACNP
ISSN journal
00079235
Volume
47
Issue
3
Year of publication
1997
Pages
134 - 149
Database
ISI
SICI code
0007-9235(1997)47:3<134:2FOTBD>2.0.ZU;2-W
Abstract
This study reports on the 20-year follow-up of the women diagnosed wit h breast cancer in the Breast Cancer Detection Demonstration Project ( BCDDP) between 1973 and 1980. This project provided 5 years of screeni ng with physical examination and two-view mammography for 280,000 volu nteer women across the United States. Based on a 96% follow-up from 19 93 to 1995 of the 4,051 women with breast cancer available for analysi s, 2,658 (66%) were alive and 1,393 (34%) were dead A high proportion of the cancers were detected by mammography alone, and 28.6% of all th e cancers were smaller than 1.0 cm. Survival rates were calculated by life table method with deaths from breast cancer as the outcome. The a djusted survival rate for the entire group was 80.5%, and the observed survival rate was 61.7%. Adjusted and observed survival rates were 97 .2% and 78.5%, respectively, for women with noninvasive cancers and 78 .2% and 59.3%, respectively, for those with invasive cancers. Lymph no de status and the size of the cancer at diagnosis were prognostic indi cators of survival in the BCDDP. Women with invasive cancers and negat ive lymph nodes had an 85.5% breast cancer survival rate and a 65.6% o bserved survival rate. Adjusted survival rates for women with invasive breast cancers were 90.2% for cancers smaller than 1 cm, 80.5% for ca ncers 1.0 to 1.9 cm, 70.5% for cancers 2.0 to 4.9 cm, and 60.6% for ca ncers larger than 5 cm. Women 40 to 49 years of age demonstrated a gre ater survival with noninvasive or invasive cancers smaller than 5.0 cm compared with women 50 to 59 and 60 to 69 years of age at diagnosis. These results from the BCDDP are discussed in the context of the recen t decline in breast cancer incidence and mortality in the United State s.